{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:45Z","timestamp":1790743005171,"version":"4.1.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00702-018-1870-8","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T22:11:39Z","timestamp":1520374299000},"page":"1299-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Impulse control disorders in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Ana","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-5439","authenticated-orcid":false,"given":"Pierre-Olivier","family":"Fernagut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"1870_CR5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington, DC","edition":"5"},{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","volume":"6","author":"M Andersson","year":"1999","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6:461\u2013474. https:\/\/doi.org\/10.1006\/nbdi.1999.0259","journal-title":"Neurobiol Dis"},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/hbm.22344","volume":"35","author":"F Antonelli","year":"2014","unstructured":"Antonelli F et al (2014) Dopamine-agonists and impulsivity in Parkinson\u2019s disease: impulsive choices vs. impulsive actions. Hum Brain Mapp 35:2499\u20132506. https:\/\/doi.org\/10.1002\/hbm.22344","journal-title":"Hum Brain Mapp"},{"key":"1870_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/mds.23501","volume":"26","author":"A Antonini","year":"2011","unstructured":"Antonini A et al (2011) Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 26:464\u2013468. https:\/\/doi.org\/10.1002\/mds.23501","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"Suppl 1","key":"1870_CR4","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.parkreldis.2015.08.003","volume":"22","author":"I Aracil-Bola\u00f1os","year":"2016","unstructured":"Aracil-Bola\u00f1os I, Strafella AP (2016) Molecular imaging and neural networks in impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):S101\u2013S105. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.003","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR6","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/mds.21072","volume":"21","author":"M Avanzi","year":"2006","unstructured":"Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F (2006) Prevalence of pathological gambling in patients with Parkinson\u2019s disease. Mov Disord 21:2068\u20132072. https:\/\/doi.org\/10.1002\/mds.21072","journal-title":"Mov Disord"},{"key":"1870_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2017.01.017","volume":"37","author":"F Baig","year":"2017","unstructured":"Baig F et al (2017) Personality and addictive behaviours in early Parkinson\u2019s disease and REM sleep behaviour disorder. Parkinsonism Relat Disord 37:72\u201378. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.01.017","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/BEN-2012-120266","volume":"26","author":"S Balarajah","year":"2013","unstructured":"Balarajah S, Cavanna AE (2013) The pathophysiology of impulse control disorders in Parkinson disease. Behav Neurol 26:237\u2013244. https:\/\/doi.org\/10.3233\/BEN-2012-120266","journal-title":"Behav Neurol"},{"key":"1870_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"Bancos I, Nannenga MR, Bostwick JM, Silber MH, Erickson D, Nippoldt TB (2014) Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case\u2013control study. Clin Endocrinol 80:863\u2013868. https:\/\/doi.org\/10.1111\/cen.12375","journal-title":"Clin Endocrinol"},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ (2013) Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov Disord 28:327\u2013333. https:\/\/doi.org\/10.1002\/mds.25291","journal-title":"Mov Disord"},{"key":"1870_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","volume":"132","author":"MF Bastide","year":"2015","unstructured":"Bastide MF et al (2015) Pathophysiology of l-dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.07.002","journal-title":"Prog Neurobiol"},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/S0306-4522(99)00065-2","volume":"92","author":"C Baunez","year":"1999","unstructured":"Baunez C, Robbins TW (1999) Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92:1343\u20131356","journal-title":"Neuroscience"},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s10072-012-1224-5","volume":"34","author":"AR Bentivoglio","year":"2013","unstructured":"Bentivoglio AR, Baldonero E, Ricciardi L, De Nigris F, Daniele A (2013) Neuropsychological features of patients with Parkinson\u2019s disease and impulse control disorders. Neurol Sci 34:1207\u20131213. https:\/\/doi.org\/10.1007\/s10072-012-1224-5","journal-title":"Neurol Sci"},{"key":"1870_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/mds.26154","volume":"30","author":"R Biundo","year":"2015","unstructured":"Biundo R et al (2015) Patterns of cortical thickness associated with impulse control disorders in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 30:688\u2013695. https:\/\/doi.org\/10.1002\/mds.26154","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1870_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/014107689608900711","volume":"89","author":"K Blum","year":"1996","unstructured":"Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE (1996) The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 89:396\u2013400","journal-title":"J R Soc Med"},{"key":"1870_CR16","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/brain\/awp094","volume":"132","author":"N Bodi","year":"2009","unstructured":"Bodi N et al (2009) Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson\u2019s patients. Brain 132:2385\u20132395. https:\/\/doi.org\/10.1093\/brain\/awp094","journal-title":"Brain"},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.parkreldis.2010.02.004","volume":"16","author":"AB Bonfanti","year":"2010","unstructured":"Bonfanti AB, Gatto EM (2010) Kleptomania, an unusual impulsive control disorder in Parkinson\u2019s disease? Parkinsonism Relat Disord 16:358\u2013359. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.02.004","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10899-012-9297-x","volume":"29","author":"C Bonnaire","year":"2013","unstructured":"Bonnaire C, Bungener C, Varescon I (2013) Alexithymia and gambling: a risk factor for all gamblers? J Gambl Stud 29:83\u201396. https:\/\/doi.org\/10.1007\/s10899-012-9297-x","journal-title":"J Gambl Stud"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","volume":"84","author":"JM Bostwick","year":"2009","unstructured":"Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84:310\u2013316. https:\/\/doi.org\/10.1016\/S0025-6196(11)60538-7","journal-title":"Mayo Clin Proc"},{"key":"1870_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","volume":"3","author":"M Bourdenx","year":"2015","unstructured":"Bourdenx M et al (2015) Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression. Acta Neuropathol Commun 3:46. https:\/\/doi.org\/10.1186\/s40478-015-0222-2","journal-title":"Acta Neuropathol Commun"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbr.2014.09.002","volume":"275","author":"JC Campbell","year":"2014","unstructured":"Campbell JC, Jeyamohan SB, De La Cruz P, Chen N, Shin D, Pilitsis JG (2014) Place conditioning to apomorphine in rat models of Parkinson\u2019s disease: differences by dose and side-effect expression. Behav Brain Res 275:114\u2013119. https:\/\/doi.org\/10.1016\/j.bbr.2014.09.002","journal-title":"Behav Brain Res"},{"key":"1870_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3233\/JPD-150681","volume":"6","author":"M Canesi","year":"2016","unstructured":"Canesi M, Rusconi ML, Moroni F, Ranghetti A, Cereda E, Pezzoli G (2016) Creative thinking professional artists, and Parkinson\u2019s disease. J Parkinsons Dis 6:239\u2013246. https:\/\/doi.org\/10.3233\/JPD-150681","journal-title":"J Parkinsons Dis"},{"key":"1870_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0306-4522(99)00294-8","volume":"94","author":"MA Cenci","year":"1999","unstructured":"Cenci MA, Tranberg A, Andersson M, Hilbertson A (1999) Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic l-dopa treatment. Neuroscience 94:515\u2013527","journal-title":"Neuroscience"},{"key":"1870_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2015.08.026","volume":"82","author":"MA Cenci","year":"2015","unstructured":"Cenci MA, Francardo V, O\u2019Sullivan SS, Lindgren HS (2015) Rodent models of impulsive\u2013compulsive behaviors in Parkinson\u2019s disease: how far have we reached? Neurobiol Dis 82:561\u2013573. https:\/\/doi.org\/10.1016\/j.nbd.2015.08.026","journal-title":"Neurobiol Dis"},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.parkreldis.2012.06.003","volume":"19","author":"A Cerasa","year":"2013","unstructured":"Cerasa A et al (2013) Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement. Parkinsonism Relat Disord 19:123\u2013125. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.06.003","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/npp.2008.114","volume":"34","author":"O Chernoloz","year":"2009","unstructured":"Chernoloz O, El Mansari M, Blier P (2009) Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology 34:651\u2013661. https:\/\/doi.org\/10.1038\/npp.2008.114","journal-title":"Neuropsychopharmacology"},{"key":"1870_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1503\/jpn.110038","volume":"37","author":"O Chernoloz","year":"2012","unstructured":"Chernoloz O, El Mansari M, Blier P (2012) Long-term administration of the dopamine D3\/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain. J Psychiatry Neurosci 37:113\u2013121. https:\/\/doi.org\/10.1503\/jpn.110038","journal-title":"J Psychiatry Neurosci"},{"key":"1870_CR28","first-page":"5","volume":"55","author":"GA Christenson","year":"1994","unstructured":"Christenson GA et al (1994) Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 55:5\u201311","journal-title":"J Clin Psychiatry"},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","volume":"216","author":"R Cilia","year":"2011","unstructured":"Cilia R, van Eimeren T (2011) Impulse control disorders in Parkinson\u2019s disease: seeking a roadmap toward a better understanding. Brain Struct Funct 216:289\u2013299. https:\/\/doi.org\/10.1007\/s00429-011-0314-0","journal-title":"Brain Struct Funct"},{"key":"1870_CR30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R et al (2010) Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis 39:98\u2013104. https:\/\/doi.org\/10.1016\/j.nbd.2010.03.013","journal-title":"Neurobiol Dis"},{"key":"1870_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mds.23480","volume":"26","author":"R Cilia","year":"2011","unstructured":"Cilia R et al (2011) Pathological gambling in patients with Parkinson\u2019s disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov Disord 26:225\u2013233. https:\/\/doi.org\/10.1002\/mds.23480","journal-title":"Mov Disord"},{"key":"1870_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-016-4447-y","volume":"234","author":"PJ Cocker","year":"2017","unstructured":"Cocker PJ, Tremblay M, Kaur S, Winstanley CA (2017) Chronic administration of the dopamine D2\/3 agonist ropinirole invigorates performance of a rodent slot machine task, potentially indicative of less distractible or compulsive-like gambling behaviour. Psychopharmacology 234:137\u2013153. https:\/\/doi.org\/10.1007\/s00213-016-4447-y","journal-title":"Psychopharmacology"},{"key":"1870_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00702-012-0934-4","volume":"120","author":"F Cormier","year":"2013","unstructured":"Cormier F, Muellner J, Corvol JC (2013) Genetics of impulse control disorders in Parkinson\u2019s disease. J Neural Transm (Vienna) 120:665\u2013671. https:\/\/doi.org\/10.1007\/s00702-012-0934-4","journal-title":"J Neural Transm (Vienna)"},{"key":"1870_CR34","first-page":"81","volume":"33","author":"JR Cornelius","year":"2010","unstructured":"Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case\u2013control study. Sleep 33:81\u201387","journal-title":"Sleep"},{"key":"1870_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbr.2017.06.016","volume":"332","author":"D Dardou","year":"2017","unstructured":"Dardou D, Reyrolle L, Chassain C, Durif F (2017) Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area. Behav Brain Res 332:327\u2013336. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.016","journal-title":"Behav Brain Res"},{"key":"1870_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","volume":"235","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Bjorklund A (2012a) Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson\u2019s disease. Exp Neurol 235:306\u2013315. https:\/\/doi.org\/10.1016\/j.expneurol.2012.02.012","journal-title":"Exp Neurol"},{"key":"1870_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","volume":"45","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Lundblad M, Weikop P, Bjorklund A (2012b) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol Dis 45:939\u2013953. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.013","journal-title":"Neurobiol Dis"},{"key":"1870_CR38","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/mds.23247","volume":"25","author":"A Djamshidian","year":"2010","unstructured":"Djamshidian A et al (2010) Risk and learning in impulsive and nonimpulsive patients with Parkinson\u2019s disease. Mov Disord 25:2203\u20132210. https:\/\/doi.org\/10.1002\/mds.23247","journal-title":"Mov Disord"},{"key":"1870_CR39","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","volume":"62","author":"ML Dodd","year":"2005","unstructured":"Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377\u20131381. https:\/\/doi.org\/10.1001\/archneur.62.9.noc50009","journal-title":"Arch Neurol"},{"key":"1870_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1460-9568.1996.tb01220.x","volume":"8","author":"JP Doucet","year":"1996","unstructured":"Doucet JP et al (1996) Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci 8:365\u2013381","journal-title":"Eur J Neurosci"},{"key":"1870_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","volume":"30","author":"ED Driver-Dunckley","year":"2007","unstructured":"Driver-Dunckley ED et al (2007) Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 30:249\u2013255. https:\/\/doi.org\/10.1097\/wnf.0b013e31804c780e","journal-title":"Clin Neuropharmacol"},{"key":"1870_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2012.08.005","volume":"49","author":"M Engeln","year":"2013","unstructured":"Engeln M, Ahmed SH, Vouillac C, Tison F, Bezard E, Fernagut PO (2013a) Reinforcing properties of Pramipexole in normal and parkinsonian rats. Neurobiol Dis 49:79\u201386. https:\/\/doi.org\/10.1016\/j.nbd.2012.08.005","journal-title":"Neurobiol Dis"},{"key":"1870_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.23881","volume":"74","author":"M Engeln","year":"2013","unstructured":"Engeln M, Fasano S, Ahmed SH, Cador M, Baekelandt V, Bezard E, Fernagut PO (2013b) Levodopa gains psychostimulant-like properties after nigral dopaminergic loss. Ann Neurol 74:140\u2013144. https:\/\/doi.org\/10.1002\/ana.23881","journal-title":"Ann Neurol"},{"key":"1870_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.05.013","author":"M Engeln","year":"2016","unstructured":"Engeln M, Ansquer S, Dugast E, Bezard E, Belin D, Fernagut PO (2016a) Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.05.013","journal-title":"Neuropharmacology"},{"key":"1870_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.biopsych.2014.07.007","volume":"79","author":"M Engeln","year":"2016","unstructured":"Engeln M et al (2016b) Selective inactivation of striatal FosB\/DeltaFosB-expressing neurons alleviates l-DOPA-induced dyskinesia. Biol Psychiatry 79:354\u2013361. https:\/\/doi.org\/10.1016\/j.biopsych.2014.07.007","journal-title":"Biol Psychiatry"},{"key":"1870_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O\u2019Sullivan JD, Appel S, Lawrence AD, Lees AJ (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405. https:\/\/doi.org\/10.1002\/mds.20045","journal-title":"Mov Disord"},{"key":"1870_CR47","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","volume":"65","author":"AH Evans","year":"2005","unstructured":"Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570\u20131574. https:\/\/doi.org\/10.1212\/01.wnl.0000184487.72289.f0","journal-title":"Neurology"},{"key":"1870_CR48","doi-asserted-by":"crossref","unstructured":"Fantini ML et al (2017) Sleep and REM Sleep Behavior disorder in Parkinson\u2019s disease with impulse control disorder. J Neurol Neurosurg Psychiatry","DOI":"10.1136\/jnnp-2017-316576"},{"key":"1870_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/jnnp-2014-307904","volume":"86","author":"ML Fantini","year":"2015","unstructured":"Fantini ML et al (2015) Increased risk of impulse control symptoms in Parkinson\u2019s disease with REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry 86:174\u2013179. https:\/\/doi.org\/10.1136\/jnnp-2014-307904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1870_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24181","volume":"75","author":"A Faust-Socher","year":"2014","unstructured":"Faust-Socher A, Kenett YN, Cohen OS, Hassin-Baer S, Inzelberg R (2014) Enhanced creative thinking under dopaminergic therapy in Parkinson disease. Ann Neurol 75:935\u2013942. https:\/\/doi.org\/10.1002\/ana.24181","journal-title":"Ann Neurol"},{"key":"1870_CR51","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ et al (2014) Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85:840\u2013844. https:\/\/doi.org\/10.1136\/jnnp-2013-306787","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1870_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0269881106073109","volume":"21","author":"N Giladi","year":"2007","unstructured":"Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C (2007) New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson\u2019s disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 21:501\u2013506. https:\/\/doi.org\/10.1177\/0269881106073109","journal-title":"J Psychopharmacol"},{"key":"1870_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJ (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1870_CR54","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/mds.25679","volume":"29","author":"KS Goerlich-Dobre","year":"2014","unstructured":"Goerlich-Dobre KS, Probst C, Winter L, Witt K, Deuschl G, M\u00f6ller B, van Eimeren T (2014) Alexithymia-an independent risk factor for impulsive\u2013compulsive disorders in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 29:214\u2013220. https:\/\/doi.org\/10.1002\/mds.25679","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1870_CR55","doi-asserted-by":"publisher","first-page":"e81426","DOI":"10.1371\/journal.pone.0081426","volume":"8","author":"SE Gombash","year":"2013","unstructured":"Gombash SE et al (2013) Morphological and behavioral impact of AAV2\/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system. PLoS One 8:e81426. https:\/\/doi.org\/10.1371\/journal.pone.0081426","journal-title":"PLoS One"},{"key":"1870_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0590-6","author":"M Grall-Bronnec","year":"2017","unstructured":"Grall-Bronnec M et al (2017) Dopamine agonists and impulse control disorders: a complex association. Drug Saf. https:\/\/doi.org\/10.1007\/s40264-017-0590-6","journal-title":"Drug Saf"},{"key":"1870_CR57","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","volume":"162","author":"JE Grant","year":"2005","unstructured":"Grant JE, Levine L, Kim D, Potenza MN (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184\u20132188","journal-title":"Am J Psychiatry"},{"key":"1870_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pnpbp.2016.05.004","volume":"70","author":"NA Holtz","year":"2016","unstructured":"Holtz NA, Tedford SE, Persons AL, Grasso SA, Napier TC (2016) Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 70:77\u201384. https:\/\/doi.org\/10.1016\/j.pnpbp.2016.05.004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1870_CR59","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:411\u2013415. https:\/\/doi.org\/10.1002\/mds.21872","journal-title":"Mov Disord"},{"key":"1870_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00213-010-2006-5","volume":"213","author":"PS Johnson","year":"2011","unstructured":"Johnson PS, Madden GJ, Brewer AT, Pinkston JW, Fowler SC (2011) Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats. Psychopharmacology 213:11\u201318. https:\/\/doi.org\/10.1007\/s00213-010-2006-5","journal-title":"Psychopharmacology"},{"key":"1870_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1037\/a0027117","volume":"20","author":"PS Johnson","year":"2012","unstructured":"Johnson PS, Madden GJ, Stein JS (2012) Effects of acute pramipexole on male rats\u2019 preference for gambling-like rewards II. Exp Clin Psychopharmacol 20:167\u2013172. https:\/\/doi.org\/10.1037\/a0027117","journal-title":"Exp Clin Psychopharmacol"},{"key":"1870_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.brainres.2008.07.110","volume":"1236","author":"M Keitz","year":"2008","unstructured":"Keitz M, Koerts J, Kortekaas R, Renken R, de Jong BM, Leenders KL (2008) Prefrontal cortex and striatal activation by feedback in Parkinson\u2019s disease. Brain Res 1236:225\u2013233. https:\/\/doi.org\/10.1016\/j.brainres.2008.07.110","journal-title":"Brain Res"},{"key":"1870_CR63","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","volume":"11","author":"KJ Klos","year":"2005","unstructured":"Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE (2005) Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord 11:381\u2013386. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.06.005","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR64","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/FBP0b013e3283473bcb","volume":"22","author":"MN Koffarnus","year":"2011","unstructured":"Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH (2011) Effects of selective dopaminergic compounds on a delay-discounting task. Behav Pharmacol 22:300\u2013311. https:\/\/doi.org\/10.1097\/FBP0b013e3283473bcb","journal-title":"Behav Pharmacol"},{"key":"1870_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312848","author":"J Kraemmer","year":"2016","unstructured":"Kraemmer J et al (2016) Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2015-312848","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1870_CR66","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/mds.22678","volume":"24","author":"JY Lee","year":"2009","unstructured":"Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, Jeon BS (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease. Mov Disord 24:1803\u20131810. https:\/\/doi.org\/10.1002\/mds.22678","journal-title":"Mov Disord"},{"key":"1870_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","volume":"16","author":"JY Lee","year":"2010","unstructured":"Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, Jeon BS (2010) Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 16:202\u2013207. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.12.002","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR68","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/gps.2704","volume":"27","author":"I Leroi","year":"2012","unstructured":"Leroi I, Harbishettar V, Andrews M, McDonald K, Byrne EJ, Burns A (2012) Carer burden in apathy and impulse control disorders in Parkinson\u2019s disease. Int J Geriatr Psychiatry 27:160\u2013166. https:\/\/doi.org\/10.1002\/gps.2704","journal-title":"Int J Geriatr Psychiatry"},{"key":"1870_CR69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2307\/20445472","volume":"121","author":"DJ Llewellyn","year":"2008","unstructured":"Llewellyn DJ (2008) The psychology of risk taking: toward the integration of psychometric and neuropsychological paradigms. Am J Psychol 121:363\u2013376","journal-title":"Am J Psychol"},{"key":"1870_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00213-016-4430-7","volume":"234","author":"S Loiodice","year":"2017","unstructured":"Loiodice S et al (2017) Pramipexole induced place preference after l-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications. Psychopharmacology 234:15\u201327. https:\/\/doi.org\/10.1007\/s00213-016-4430-7","journal-title":"Psychopharmacology"},{"key":"1870_CR71","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","volume":"109","author":"M Lundblad","year":"2012","unstructured":"Lundblad M, Decressac M, Mattsson B, Bjorklund A (2012) Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons. Proc Natl Acad Sci USA 109:3213\u20133219. https:\/\/doi.org\/10.1073\/pnas.1200575109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1870_CR72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1037\/a0019244","volume":"18","author":"GJ Madden","year":"2010","unstructured":"Madden GJ, Johnson PS, Brewer AT, Pinkston JW, Fowler SC (2010) Effects of pramipexole on impulsive choice in male wistar rats. Exp Clin Psychopharmacol 18:267\u2013276. https:\/\/doi.org\/10.1037\/a0019244","journal-title":"Exp Clin Psychopharmacol"},{"key":"1870_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.21770","volume":"23","author":"E Mamikonyan","year":"2008","unstructured":"Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D (2008) Long-term follow-up of impulse control disorders in Parkinson\u2019s disease. Mov Disord 23:75\u201380. https:\/\/doi.org\/10.1002\/mds.21770","journal-title":"Mov Disord"},{"key":"1870_CR74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00415-014-7361-4","volume":"262","author":"E Marechal","year":"2015","unstructured":"Marechal E, Denoiseux B, Thys E, Crosiers D, Pickut B, Cras P (2015) Impulse control disorders in Parkinson\u2019s disease: an overview from neurobiology to treatment. J Neurol 262:7\u201320. https:\/\/doi.org\/10.1007\/s00415-014-7361-4","journal-title":"J Neurol"},{"key":"1870_CR900","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2018.02.004","author":"A Marques","year":"2015","unstructured":"Marques A, Figorilli M, Pereira B, Derost P, Debilly B, Beudin P, Vidal T, Durif F (2018) Psycho-behavioral profile of Parkinson\u2019s disease patients with RLS: a cross sectional-study. Sleep Med. https:\/\/doi.org\/10.1016\/j.sleep.2018.02.004","journal-title":"Sleep Med"},{"key":"1870_CR75","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuropharm.2014.09.026","volume":"89","author":"PN McCormick","year":"2015","unstructured":"McCormick PN, Fletcher PJ, Wilson VS, Browne JD, Nobrega JN, Remington GJ (2015) Low dose pramipexole causes D3 receptor-independent reduction of locomotion and responding for a conditioned reinforcer. Neuropharmacology 89:225\u2013231. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.09.026","journal-title":"Neuropharmacology"},{"key":"1870_CR76","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/jpet.102.039867","volume":"303","author":"MJ Millan","year":"2002","unstructured":"Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791\u2013804. https:\/\/doi.org\/10.1124\/jpet.102.039867","journal-title":"J Pharmacol Exp Ther"},{"key":"1870_CR77","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/mds.23016","volume":"25","author":"SS O\u2019Sullivan","year":"2010","unstructured":"O\u2019Sullivan SS, Djamshidian A, Evans AH, Loane CM, Lees AJ, Lawrence AD (2010) Excessive hoarding in Parkinson\u2019s disease. Mov Disord 25:1026\u20131033. https:\/\/doi.org\/10.1002\/mds.23016","journal-title":"Mov Disord"},{"key":"1870_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr003","author":"SS O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS et al (2011) Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive\u2013compulsive behaviours. Brain. https:\/\/doi.org\/10.1093\/brain\/awr003","journal-title":"Brain"},{"key":"1870_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2013.05.042","volume":"252","author":"O Ouachikh","year":"2013","unstructured":"Ouachikh O, Dieb W, Durif F, Hafidi A (2013) Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area. Behav Brain Res 252:24\u201331. https:\/\/doi.org\/10.1016\/j.bbr.2013.05.042","journal-title":"Behav Brain Res"},{"key":"1870_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2013.12.021","volume":"262","author":"O Ouachikh","year":"2014","unstructured":"Ouachikh O, Dieb W, Durif F, Hafidi A (2014) Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats. Behav Brain Res 262:1\u20137. https:\/\/doi.org\/10.1016\/j.bbr.2013.12.021","journal-title":"Behav Brain Res"},{"key":"1870_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuropharm.2016.11.014","volume":"114","author":"R Pes","year":"2017","unstructured":"Pes R et al (2017) Pramipexole enhances disadvantageous decision-making: lack of relation to changes in phasic dopamine release. Neuropharmacology 114:77\u201387. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.014","journal-title":"Neuropharmacology"},{"key":"1870_CR82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2013.02.032","volume":"21","author":"AL Phu","year":"2014","unstructured":"Phu AL et al (2014) Effect of impulse control disorders on disability and quality of life in Parkinson\u2019s disease patients. J Clin Neurosci 21:63\u201366. https:\/\/doi.org\/10.1016\/j.jocn.2013.02.032","journal-title":"J Clin Neurosci"},{"key":"1870_CR83","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1601-183X.2010.00621.x","volume":"9","author":"KK Pitchers","year":"2010","unstructured":"Pitchers KK, Frohmader KS, Vialou V, Mouzon E, Nestler EJ, Lehman MN, Coolen LM (2010) DeltaFosB in the nucleus accumbens is critical for reinforcing effects of sexual reward. Genes Brain Behav 9:831\u2013840. https:\/\/doi.org\/10.1111\/j.1601-183X.2010.00621.x","journal-title":"Genes Brain Behav"},{"key":"1870_CR84","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00415-012-6506-6","volume":"259","author":"M Poletti","year":"2012","unstructured":"Poletti M, Bonuccelli U (2012a) Impulse control disorders in Parkinson\u2019s disease: the role of personality and cognitive status. J Neurol 259:2269\u20132277. https:\/\/doi.org\/10.1007\/s00415-012-6506-6","journal-title":"J Neurol"},{"key":"1870_CR85","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00415-011-6302-8","volume":"259","author":"M Poletti","year":"2012","unstructured":"Poletti M, Bonuccelli U (2012b) Personality traits in patients with Parkinson\u2019s disease: assessment and clinical implications. J Neurol 259:1029\u20131038. https:\/\/doi.org\/10.1007\/s00415-011-6302-8","journal-title":"J Neurol"},{"key":"1870_CR86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/brain\/aws326","volume":"136","author":"M Politis","year":"2013","unstructured":"Politis M et al (2013) Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson\u2019s disease. Brain 136:400\u2013411. https:\/\/doi.org\/10.1093\/brain\/aws326","journal-title":"Brain"},{"key":"1870_CR87","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neuroscience.2017.08.017","volume":"361","author":"A Quiroga-Varela","year":"2017","unstructured":"Quiroga-Varela A, Aguilar E, Iglesias E, Obeso JA, Marin C (2017) Short- and long-term effects induced by repeated 6-OHDA intraventricular administration: a new progressive and bilateral rodent model of Parkinson\u2019s disease. Neuroscience 361:144\u2013156. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.08.017","journal-title":"Neuroscience"},{"key":"1870_CR88","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00702-012-0933-5","volume":"120","author":"NJ Ray","year":"2013","unstructured":"Ray NJ, Strafella AP (2013) Imaging impulse control disorders in Parkinson\u2019s disease and their relationship to addiction. J Neural Transm 120:659\u2013664. https:\/\/doi.org\/10.1007\/s00702-012-0933-5","journal-title":"J Neural Transm"},{"key":"1870_CR89","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ et al (2012) Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis 48:519\u2013525. https:\/\/doi.org\/10.1016\/j.nbd.2012.06.021","journal-title":"Neurobiol Dis"},{"key":"1870_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbr.2012.04.027","volume":"233","author":"JL Riddle","year":"2012","unstructured":"Riddle JL, Rokosik SL, Napier TC (2012) Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson\u2019s disease and controls. Behav Brain Res 233:15\u201323. https:\/\/doi.org\/10.1016\/j.bbr.2012.04.027","journal-title":"Behav Brain Res"},{"key":"1870_CR91","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mds.26223","volume":"30","author":"I Rieu","year":"2015","unstructured":"Rieu I et al (2015) International validation of a behavioral scale in Parkinson\u2019s disease without dementia. Mov Disord 30:705\u2013713. https:\/\/doi.org\/10.1002\/mds.26223","journal-title":"Mov Disord"},{"key":"1870_CR92","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13034","volume":"23","author":"A Rizos","year":"2016","unstructured":"Rizos A et al (2016) A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists. Eur J Neurol 23:1255\u20131261. https:\/\/doi.org\/10.1111\/ene.13034","journal-title":"Eur J Neurol"},{"key":"1870_CR93","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrn3111","volume":"12","author":"AJ Robison","year":"2011","unstructured":"Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623\u2013637. https:\/\/doi.org\/10.1038\/nrn3111","journal-title":"Nat Rev Neurosci"},{"key":"1870_CR94","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/npp.2011.325","volume":"37","author":"SL Rokosik","year":"2012","unstructured":"Rokosik SL, Napier TC (2012) Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson\u2019s disease and controls. Neuropsychopharmacology 37:1397\u20131408. https:\/\/doi.org\/10.1038\/npp.2011.325","journal-title":"Neuropsychopharmacology"},{"key":"1870_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-1331.2009.02792.x","volume":"17","author":"M Rossi","year":"2010","unstructured":"Rossi M et al (2010) Decision-making in Parkinson\u2019s disease patients with and without pathological gambling. Eur J Neurol 17:97\u2013102. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02792.x","journal-title":"Eur J Neurol"},{"key":"1870_CR96","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/mds.22472","volume":"24","author":"G Santangelo","year":"2009","unstructured":"Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 24:899\u2013905. https:\/\/doi.org\/10.1002\/mds.22472","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1870_CR97","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s10072-013-1355-3","volume":"34","author":"G Santangelo","year":"2013","unstructured":"Santangelo G, Trojano L, Barone P, Grossi D, Vitale C (2013) Impulse control disorders and cognitive dysfunctions in patients with Parkinson\u2019s disease. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 34:2045\u20132046. https:\/\/doi.org\/10.1007\/s10072-013-1355-3","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"1870_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2017.01.013","volume":"374","author":"G Santangelo","year":"2017","unstructured":"Santangelo G, Piscopo F, Barone P, Vitale C (2017) Personality in Parkinson\u2019s disease: clinical, behavioural and cognitive correlates. J Neurol Sci 374:17\u201325. https:\/\/doi.org\/10.1016\/j.jns.2017.01.013","journal-title":"J Neurol Sci"},{"key":"1870_CR99","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.parkreldis.2013.06.018","volume":"19","author":"MK Scullin","year":"2013","unstructured":"Scullin MK et al (2013) Sleep and impulsivity in Parkinson\u2019s disease. Parkinsonism Relat Disord 19:991\u2013994. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.06.018","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR100","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jocn.2007.01.009","volume":"14","author":"A Singh","year":"2007","unstructured":"Singh A, Kandimala G, Dewey RB Jr, O\u2019Suilleabhain P (2007) Risk factors for pathologic gambling and other compulsions among Parkinson\u2019s disease patients taking dopamine agonists. J Clin Neurosci 14:1178\u20131181. https:\/\/doi.org\/10.1016\/j.jocn.2007.01.009","journal-title":"J Clin Neurosci"},{"key":"1870_CR101","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00415-009-5301-5","volume":"257","author":"C Siri","year":"2010","unstructured":"Siri C et al (2010) Cognitive status of patients with Parkinson\u2019s disease and pathological gambling. J Neurol 257:247\u2013252. https:\/\/doi.org\/10.1007\/s00415-009-5301-5","journal-title":"J Neurol"},{"key":"1870_CR102","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/mds.26160","volume":"30","author":"C Siri","year":"2015","unstructured":"Siri C et al (2015) Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders. Mov Disord Off J Mov Disord Soc 30:696\u2013704. https:\/\/doi.org\/10.1002\/mds.26160","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1870_CR103","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD et al (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376\u20131385. https:\/\/doi.org\/10.1093\/brain\/awp054","journal-title":"Brain"},{"key":"1870_CR104","doi-asserted-by":"publisher","first-page":"e0122063","DOI":"10.1371\/journal.pone.0122063","volume":"10","author":"SE Tedford","year":"2015","unstructured":"Tedford SE, Persons AL, Napier TC (2015) Dopaminergic lesions of the dorsolateral striatum in rats increase delay discounting in an impulsive choice task. PloS One 10:e0122063. https:\/\/doi.org\/10.1371\/journal.pone.0122063","journal-title":"PloS One"},{"key":"1870_CR105","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2015.10.013","volume":"24","author":"A Tessitore","year":"2016","unstructured":"Tessitore A et al (2016) Cortical thickness changes in patients with Parkinson\u2019s disease and impulse control disorders. Parkinsonism Relat Disord 24:119\u2013125. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.10.013","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR106","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cortex.2017.06.008","volume":"94","author":"A Tessitore","year":"2017","unstructured":"Tessitore A et al (2017) Resting-state brain networks in patients with Parkinson\u2019s disease and impulse control disorders. Cortex 94:63\u201372. https:\/\/doi.org\/10.1016\/j.cortex.2017.06.008","journal-title":"Cortex"},{"key":"1870_CR107","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/ejn.13332","volume":"45","author":"M Tremblay","year":"2017","unstructured":"Tremblay M, Silveira MM, Kaur S, Hosking JG, Adams WK, Baunez C, Winstanley CA (2017) Chronic D2\/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns. Eur J Neurosci 45:159\u2013166. https:\/\/doi.org\/10.1111\/ejn.13332","journal-title":"Eur J Neurosci"},{"key":"1870_CR108","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.parkreldis.2011.10.019","volume":"18","author":"A Vallelunga","year":"2012","unstructured":"Vallelunga A, Flaibani R, Formento-Dojot P, Biundo R, Facchini S, Antonini A (2012) Role of genetic polymorphisms of the dopaminergic system in Parkinson\u2019s disease patients with impulse control disorders. Parkinsonism Relat Disord 18:397\u2013399. https:\/\/doi.org\/10.1016\/j.parkreldis.2011.10.019","journal-title":"Parkinsonism Relat Disord"},{"key":"1870_CR109","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1038\/sj.npp.npp2009124","volume":"34","author":"T Eimeren van","year":"2009","unstructured":"van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP (2009) Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson\u2019s disease? Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 34:2758\u20132766. https:\/\/doi.org\/10.1038\/sj.npp.npp2009124","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"1870_CR110","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/npp.2014.98","volume":"39","author":"C Velazquez-Sanchez","year":"2014","unstructured":"Velazquez-Sanchez C, Ferragud A, Moore CF, Everitt BJ, Sabino V, Cottone P (2014) High trait impulsivity predicts food addiction-like behavior in the rat. Neuropsychopharmacology 39:2463\u20132472. https:\/\/doi.org\/10.1038\/npp.2014.98","journal-title":"Neuropsychopharmacology"},{"key":"1870_CR111","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson\u2019s disease: the SCOPA-PC. Mov Disord 22:2221\u20132228. https:\/\/doi.org\/10.1002\/mds.21696","journal-title":"Mov Disord"},{"key":"1870_CR112","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mds.23567","volume":"26","author":"C Vitale","year":"2011","unstructured":"Vitale C, Santangelo G, Trojano L, Verde F, Rocco M, Grossi D, Barone P (2011) Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson\u2019s disease. Mov Disord 26:830\u2013836. https:\/\/doi.org\/10.1002\/mds.23567","journal-title":"Mov Disord"},{"key":"1870_CR113","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64:1089\u20131096. https:\/\/doi.org\/10.1001\/archneur.64.8.1089","journal-title":"Arch Neurol"},{"key":"1870_CR114","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"V Voon","year":"2006","unstructured":"Voon V et al (2006) Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66:1750\u20131752. https:\/\/doi.org\/10.1212\/01.wnl.0000218206.20920.4d","journal-title":"Neurology"},{"key":"1870_CR115","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00213-009-1697-y","volume":"207","author":"V Voon","year":"2010","unstructured":"Voon V et al (2010) Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology 207:645\u2013659. https:\/\/doi.org\/10.1007\/s00213-009-1697-y","journal-title":"Psychopharmacology"},{"key":"1870_CR116","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2377-11-117","volume":"11","author":"V Voon","year":"2011","unstructured":"Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Doring F (2011a) Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 11:117. https:\/\/doi.org\/10.1186\/1471-2377-11-117","journal-title":"BMC Neurol"},{"key":"1870_CR117","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ana.22356","volume":"69","author":"V Voon","year":"2011","unstructured":"Voon V et al (2011b) Impulse control disorders in Parkinson disease: a multicenter case\u2013control study. Ann Neurol 69:986\u2013996. https:\/\/doi.org\/10.1002\/ana.22356","journal-title":"Ann Neurol"},{"key":"1870_CR118","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C et al (2014) Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord 29:904\u2013911. https:\/\/doi.org\/10.1002\/mds.25886","journal-title":"Mov Disord"},{"key":"1870_CR119","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub D et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969\u2013973. https:\/\/doi.org\/10.1001\/archneur.63.7.969","journal-title":"Arch Neurol"},{"key":"1870_CR120","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D et al (2009) Validation of the questionnaire for impulsive\u2013compulsive disorders in Parkinson\u2019s disease. Mov Disord 24:1461\u20131467. https:\/\/doi.org\/10.1002\/mds.22571","journal-title":"Mov Disord"},{"key":"1870_CR121","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D et al (2010) Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67:589\u2013595. https:\/\/doi.org\/10.1001\/archneurol.2010.65","journal-title":"Arch Neurol"},{"key":"1870_CR122","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A (2012) Questionnaire for impulsive\u2013compulsive disorders in Parkinson\u2019s disease\u2014Rating Scale. Mov Disord 27:242\u2013247. https:\/\/doi.org\/10.1002\/mds.24023","journal-title":"Mov Disord"},{"key":"1870_CR123","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","volume":"80","author":"D Weintraub","year":"2013","unstructured":"Weintraub D, Papay K, Siderowf A, Parkinson\u2019s Progression Markers I (2013) Screening for impulse control symptoms in patients with de novo Parkinson disease: a case\u2013control study. Neurology 80:176\u2013180. https:\/\/doi.org\/10.1212\/WNL.0b013e31827b915c","journal-title":"Neurology"},{"key":"1870_CR124","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Mov Disord 30:121\u2013127. https:\/\/doi.org\/10.1002\/mds.26016","journal-title":"Mov Disord"},{"key":"1870_CR125","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH et al (2009) The distinct cognitive syndromes of Parkinson\u2019s disease: 5\u00a0year follow-up of the CamPaIGN cohort. Brain J Neurol 132:2958\u20132969. https:\/\/doi.org\/10.1093\/brain\/awp245","journal-title":"Brain J Neurol"},{"key":"1870_CR126","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2012.12.011","volume":"70","author":"Y Zengin-Toktas","year":"2013","unstructured":"Zengin-Toktas Y, Authier N, Denizot H, Chassain C, Hafidi A, Llorca PM, Durif F (2013) Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and l-dopa, in bilateral 6-OHDA-lesioned rat. Neuropharmacology 70:74\u201382. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.011","journal-title":"Neuropharmacology"},{"key":"1870_CR127","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/1467-6494.00124","volume":"68","author":"M Zuckerman","year":"2000","unstructured":"Zuckerman M, Kuhlman DM (2000) Personality and risk-taking: common biosocial factors. J Pers 68:999\u20131029","journal-title":"J Pers"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1870-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1870-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1870-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T05:29:17Z","timestamp":1570858157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1870-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1870-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}